Generally, CD4+ T cell subsets have varied impacts on tumor growth while they play a pivotal helper role in orchestrating cancer immunity, including Th1, Th2, Th9, Th17, Tregs, CD4+ CTL and T follicular helper cells, which present diverse functions, considered to be positive or negative immune cells in antitumor immunity. The gene discussed is CD4; the disease is neoplasm.